17-Jul-2020 - Waters Corporation

Waters Corporation Names Udit Batra President and Chief Executive Officer

Dr. Batra succeeds Christopher O’Connell

Waters Corporation announced that Udit Batra, Ph.D. has been named the Company’s President and Chief Executive Officer, effective September 1, 2020. He will also join Waters’ Board of Directors at that time. Dr. Batra succeeds Christopher O’Connell who will remain in his current roles as President and Chief Executive Officer, and as a member of the Board until September 1, 2020. As previously announced, Mr. O’Connell will also remain with Waters as an advisor until the end of this year to support the transition.

Dr. Batra brings to Waters more than two decades of leadership and operational expertise in the healthcare and life sciences industry, including a proven track record of driving results at the top of the industry and successfully managing a global organization. Most recently, Dr. Batra served as Chief Executive Officer of the $7.7 billion Life Science business of publicly traded Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the United States and Canada. In this role, he led the business’ successful integration of Sigma-Aldrich, which was acquired in 2015, resulting in the creation of MilliporeSigma. Since that time, Dr. Batra oversaw a strategic transformation of the business and drove above-market organic sales growth and margins, which remain the highest among MilliporeSigma’s integrated peers. Prior to that, Dr. Batra served as President and Chief Executive Officer of the global Consumer Health business of Merck KGaA, Darmstadt, Germany, where he led a turnaround that almost doubled its profitability and achieved organic growth rates in the top tier of the consumer health industry.

“We are pleased to have identified such an accomplished and experienced candidate and are confident that Udit is the right leader to take Waters to the next level,” said Dr. Flemming Ornskov, Chairman of the Board. “His focus on commercial execution and innovation, proven ability to build strong and collaborative cultures and intense commitment to serving customers have translated into tangible results. Building on Waters’ strong foundation, we look forward to the Company’s next phase of innovation and growth with Udit at the helm. We are grateful for the continued hard work and leadership of Chris and the entire Waters team to remain focused on our business, continue our progress and ensure a seamless transition.”

Dr. Batra said, “As a research engineer, I have a deep knowledge of Waters and TA instruments, and I have long admired the Company and its global impact. Waters’ team of world-renowned scientists, researchers and other professionals has consistently delivered scientific and technological excellence to enhance human health and well-being. With a continued focus on organic innovation, strategic M&A and disciplined capital allocation, I am confident we will capitalize on Waters’ significant growth opportunities.”

“Throughout my career, I have focused on starting with listening and learning, embracing challenges and working with talented people. I join Waters with energy and a shared passion for technology development and serving our customers to drive value for shareholders while making the world a better place,” continued Dr. Batra.

Facts, background information, dossiers
  • Waters
  • Udit Batra
More about Waters
  • News

    Waters to Acquire Andrew Alliance

    Waters Corporation announced that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves t ... more

    Waters acquires DESI-MS technology from Prosolia

    Waters Corporation, Prosolia, Inc. and the Purdue Research Foundation announced that Waters® acquired exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and PRF. "The acquisition of DESI technology bolsters Waters' p ... more

    Doug Berthiaume to Retire as Chairman of the Board of Waters Corporation

    Waters Corporation announced that Douglas A. Berthiaume will retire as Chairman of the Board of Directors of the Company, effective December 31, 2017. The Board of Directors has elected Christopher J. O'Connell, President and Chief Executive Officer, as its new Chairman effective January 1, ... more

  • Products

    Making Liquid Chromatography and High-Resolution Mass Spectrometry (LC-MS) Smarter for Biopharma

    Monitor biopharma critical quality attributes for drug release Use LC-MS for routine analyses without tedious optimization Self-calibrating, self-troubleshooting and easy to maintenance more

  • Catalogs

    Waters Quality Parts, Chromatography Columns and Supplies Catalog

    Our products are manufactured to industry benchmark quality requirements by our world-class manufacturing organization and supported by our highly skilled sales and support teams more

  • Videos

    Making Liquid Chromatography and High-Resolution Mass Spectrometry (LC-MS) Smarter for Biopharma

    For biopharmaceutical organizations who need the power and performance of LC-MS for routine screening and multi-attribute monitoring (MAM), with the BioAccord™ Waters has designed the first SmartMS™-enabled biopharma LC-MS solution. We’re used to turning on a device and using it immediately ... more

    Self-optimizing LC-MS System for Biopharmaceutical Analyses

    The BioAccord system enables even users without expert knowledge to generate and evaluate LC-MS data on the spot in the biopharmaceutical lab, tasks that until now had to be performed in centralized MS laboratories. From development to QC, the system makes the analysis of biotherapeutic pro ... more

    The Solution for Your Daily Bioseparations Challenges

    Engineered with bio-inert flow paths made of non-stainless-steel and iron-free materials, the ACQUITY Arc Bio System keeps large molecules intact and on the move, for better sample recovery and minimal carryover, whether the chromatographic mode is reversed phase (RP), ion exchange (IEX), s ... more

  • Companies

    Waters GmbH

    For fifty years, Waters Corp. has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance. Waters designs, manufactures, sells and services ultra performance liquid chromatography (UPLC), high performance liquid ... more

    Waters SpA

    Since 1958, Waters has offered total solutions in High Performance Liquid Chromatography (HPLC). With our products and services we set the standards in HPLC. Waters Corporation is a multinational, publicly traded (NYSE: WAT) company headquartered in Milford, Massachusetts, USA. The company ... more

    Waters Ges.m.b.H.

    Since 1958 Waters offers complete solutions in High Performance Liquid Chromatography (HPLC). With our products and services we set the standards in HPLC. Waters Corporation is a multinational, publicly traded (NYSE: WAT) company headquartered in Milford, Massachusetts, USA. The company ha ... more